The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 115,636 | 755,000 | SH | SOLE | 755,000 | 0 | 0 | ||
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 69,997 | 1,035,000 | SH | SOLE | 1,035,000 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 11,216 | 1,715,000 | SH | SOLE | 1,715,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 8,498 | 998,565 | SH | SOLE | 998,565 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 34,878 | 2,981,000 | SH | SOLE | 2,981,000 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 5,335 | 688,330 | SH | SOLE | 688,330 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,722 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 216,909 | 572,500 | SH | SOLE | 572,500 | 0 | 0 | ||
ARK ETF TR | GENOMIC REV ETF | 00214Q302 | 23,618 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 50,667 | 1,438,999 | SH | SOLE | 1,438,999 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 141,238 | 3,355,623 | SH | SOLE | 3,355,623 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 4,905 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 231,179 | 3,499,000 | SH | SOLE | 3,499,000 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 206,899 | 6,652,700 | SH | SOLE | 6,652,700 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 30,225 | 2,080,200 | SH | SOLE | 2,080,200 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 4,950 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 39,409 | 4,265,000 | SH | SOLE | 4,265,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 89,849 | 440,566 | SH | SOLE | 440,566 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 94,107 | 2,525,000 | SH | SOLE | 2,525,000 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 2,742 | 755,329 | SH | SOLE | 755,329 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 16,019 | 2,950,000 | SH | SOLE | 2,950,000 | 0 | 0 | ||
CATALENT INC | COM | 148806102 | 102,462 | 955,000 | SH | SOLE | 955,000 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 7,266 | 865,000 | SH | SOLE | 865,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 5,300 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 5,532 | 1,850,000 | SH | SOLE | 1,850,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 15,780 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
ELEVANCE HEALTH INC | COM | 036752103 | 212,818 | 441,000 | SH | SOLE | 441,000 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 5,542 | 995,000 | SH | SOLE | 995,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 7,749 | 2,460,000 | SH | SOLE | 2,460,000 | 0 | 0 | ||
FIELD TRIP HEALTH LTD | COM | 31656R102 | 2,500 | 2,976,000 | SH | SOLE | 2,976,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 1,953 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,984 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 148,106 | 1,856,900 | SH | SOLE | 1,856,900 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 192,985 | 412,300 | SH | SOLE | 412,300 | 0 | 0 | ||
HYPERFINE INC | COM CL A | 44916K106 | 3,353 | 1,503,754 | SH | SOLE | 1,503,754 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 41,027 | 2,972,947 | SH | SOLE | 2,972,947 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 50,369 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 58,240 | 1,125,194 | SH | SOLE | 1,125,194 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 44,266 | 775,504 | SH | SOLE | 775,504 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 15,371 | 1,392,300 | SH | SOLE | 1,392,300 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 4,138 | 430,117 | SH | SOLE | 430,117 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 9,673 | 62,000 | SH | SOLE | 62,000 | 0 | 0 | ||
JOHNSON & JOHNSON | COM | 478160104 | 159,795 | 900,200 | SH | SOLE | 900,200 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 25,880 | 204,570 | SH | SOLE | 204,570 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 33,494 | 4,050,000 | SH | SOLE | 4,050,000 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 55,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 197,780 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 126,830 | 388,800 | SH | SOLE | 388,800 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 10 | 57,770 | SH | SOLE | 57,770 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 5,086 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 48,521 | 1,369,100 | SH | SOLE | 1,369,100 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 143,062 | 1,467,600 | SH | SOLE | 1,467,600 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 17,421 | 1,414,082 | SH | SOLE | 1,414,082 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 28 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 15,730 | 4,855,000 | SH | SOLE | 4,855,000 | 0 | 0 | ||
ONCOSEC MED INC | COM | 68234L306 | 2,185 | 2,945,000 | SH | SOLE | 2,945,000 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 2,080 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 4,880 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 2,643 | 4,405,000 | SH | SOLE | 4,405,000 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 16,203 | 1,919,800 | SH | SOLE | 1,919,800 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 25,824 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
SCIENCE 37 HOLDINGS INC | COM | 808644108 | 864 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 1,785 | 959,524 | SH | SOLE | 959,524 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 97,317 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
SEASPINE HLDGS CORP | COM | 81255T108 | 11,357 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 1,197 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
SENTINELONE INC | CL A | 81730H109 | 4,771 | 204,500 | SH | SOLE | 204,500 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 13,200 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLD CRPI | CLASS A ORD SHS | G8253W109 | 1,990 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 1,942 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253T106 | 1,978 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 1,944 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 139,256 | 1,875,000 | SH | SOLE | 1,875,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 104,858 | 5,450,000 | SH | SOLE | 5,450,000 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 3,686 | 813,640 | SH | SOLE | 813,640 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 88,267 | 1,479,500 | SH | SOLE | 1,479,500 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 170,980 | 725,600 | SH | SOLE | 725,600 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 124,401 | 242,200 | SH | SOLE | 242,200 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 223,459 | 793,000 | SH | SOLE | 793,000 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 19,312 | 758,211 | SH | SOLE | 758,211 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 13,689 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 100,763 | 3,585,881 | SH | SOLE | 3,585,881 | 0 | 0 |